Exosens

Based in France, Exosens develops advanced amplification, detection, and imaging technologies for high-tech applications, focusing on sectors such as defense, industrial control, and life sciences. Exosens is a French technology company specializing in the provision of advanced detection and imaging systems. Founded in 1937, the company has successfully raised EUR 46. 00 mn through a PIPE funding round, with Bpifrance Investissement being a notable investor.

Its headquarters is located in France, and to date, Exosens has completed 4 significant deals, with the most recent occurring on June 7, 2024. Exosens specializes in advanced amplification, detection, and imaging technologies, offering high-end electro-optical components such as traveling wave tubes, advanced cameras, and neutron and gamma radiation detectors. These products are particularly utilized in defense, surveillance, nuclear instrumentation, industrial control, and life sciences, enabling high-resolution imaging and detection capabilities for a diverse client base, including defense agencies and research institutions globally. In 2023, Exosens reported a revenue of EUR 315,863,355.

30 with an EBITDA of EUR 85,744,065. 40. The company primarily engages in B2B transactions, providing tailored solutions to sectors that require precision and safety, such as defense contractors and scientific research organizations. Exosens plans to leverage recent funding to support new product developments and expand into new markets.

Following a successful IPO on June 7, 2024, where the company raised EUR 350 mn by selling shares at EUR 20 each, Exosens aims to enhance its product offerings and target growth in international markets, particularly in Europe and North America.